Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Vaneck Biotech ETF (BBH)

Vaneck Biotech ETF (BBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
VanEck Launches Robotics ETF (IBOT)

VanEck today announced the launch of the VanEck Robotics ETF (IBOT) , a thematic equity ETF offering exposure to the leading global companies that are driving and benefiting from the growth of the robotics...

ESPO : 63.27 (+0.32%)
SMH : 223.30 (+1.51%)
BBH : 164.06 (-0.34%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 164.06 (-0.34%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
VRTX : 422.78 (+0.90%)
IBB : 133.40 (-0.01%)
XBI : 88.14 (-0.94%)
ETFs in Focus on Sanofi and Regeneron's COPD Drug Data

Shares of drugmakers Sanofi and Regeneron surged more than 6% on Mar 23 on COPD drug data.

REGN : 973.80 (+0.60%)
SNY : 49.28 (+1.21%)
IBB : 133.40 (-0.01%)
BBH : 164.06 (-0.34%)
IBBQ : 21.69 (-0.82%)
PINK : 29.49 (-0.10%)
How Are Biotech ETFs Reacting to Q4 Earnings Releases?

The latest earnings from some of the big biotech players came in at mixed this reporting season.

BIIB : 221.50 (-0.56%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
IBB : 133.40 (-0.01%)
HZNP : 116.30 (+0.04%)
XBI : 88.14 (-0.94%)
BBH : 164.06 (-0.34%)
5 Least-Hurt Biotech ETFs of the Last Week

Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.

REGN : 973.80 (+0.60%)
BMY : 44.94 (+0.45%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
IBB : 133.40 (-0.01%)
LABD : 8.82 (+2.80%)
BBH : 164.06 (-0.34%)
FBT : 148.98 (+0.14%)
PBE : 63.58 (-0.77%)
BBP : 55.20 (-0.21%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 164.06 (-0.34%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
VRTX : 422.78 (+0.90%)
IBB : 133.40 (-0.01%)
XBI : 88.14 (-0.94%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 164.06 (-0.34%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
VRTX : 422.78 (+0.90%)
IBB : 133.40 (-0.01%)
XBI : 88.14 (-0.94%)
How Are Biotech ETFs Reacting to Q3 Earnings Releases?

Biotech earnings have come in upbeat in the third quarter.

BIIB : 221.50 (-0.56%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
IBB : 133.40 (-0.01%)
XBI : 88.14 (-0.94%)
BBH : 164.06 (-0.34%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 164.06 (-0.34%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
VRTX : 422.78 (+0.90%)
IBB : 133.40 (-0.01%)
XBI : 88.14 (-0.94%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 164.06 (-0.34%)
AMGN : 310.15 (-0.87%)
GILD : 65.96 (+2.14%)
VRTX : 422.78 (+0.90%)
IBB : 133.40 (-0.01%)
XBI : 88.14 (-0.94%)

Barchart Exclusives

2 Silver Mining Stocks to Buy While They're Cheap
Here are two low-priced silver mining stocks that analysts expect to rally from here. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar